1. Dr. Miriam Davis, LLC
Medical Writer & Editor
13420 Montvale Drive — Silver Spring, Maryland 20904
(301) 989-1163 — Fax: (301) 989-1184
MirDavis@verizon.net
_________________________________________________________________________________
PROFILE
Co-Author or Editor of scientific articles in top-tier medical journals including JAMA, Nature
Reviews Drug Discovery, Neurology, Science, Journal of Molecular Medicine, & Pain
Award-winning co-authored publication in the American Journal of Psychiatry
Medical News Feature Writer for Medscape Medical News, Univadis Medical News
Chapter author and/or Editor of three major mental health reports by the US Surgeon General
Chapter author of 3 chapters for Textbook of Bipolar Disorder by F. Goodwyn and K. Jamison
Versatile track record of nearly 100 peer-reviewed publications (see Publications section), 34 of which
were for the Institute of Medicine of the National Academy of Science
Over 10 years experience in a series of high-level US Government health policy positions
PhD and MA degrees in Biology—both degrees earned at Princeton University
___________________________________________________________________________________
Independent Medical Writer & Editor: 1992-present
q Offer a blend of medical writing, editing, rewriting, and scientific expertise as well as strong credibility via
scholarly affiliation with Massachusetts General Hospital’s Department of Medicine.
q Specialize in writing scientific manuscripts, news stories, abstracts, reports, literature reviews, conference
proceedings, textbook chapters & other types of publications. Current and former clients: Department of
Defense, Department of Veterans’ Affairs, U.S. Surgeon General, SAMHSA, US President, National
Institutes of Health, National Cancer Institute, others.
Consultant in Medicine at Mass General Hospital/Harvard Medical School 2007-2015
q Write and edit peer-review manuscripts in immunology, autoimmune disease, type 1 diabetes, stem cells.
Director, Office of Policy Development 1990-1992
U.S. National Institute of Environmental Health Sciences (NIEHS), Bethesda, MD 20892
q Supervised the selection of drugs and chemicals tested by the National Toxicology Program, the Nation's
premier toxicological research and testing program.
Senior Policy Analyst 1983-1990
Office of the Assistant Secretary for Health, U.S. Public Health Service, Washington, DC 20201
q Served as policy Analyst for the Assistant Secretary for Health, a public health official. Held position as a
Desk Officer for FDA.
EDUCATION
Ph.D., Biology / Neuroscience — Princeton University, 1982
M.A., Biology / Neuroscience — Princeton University, 1979
B.A., Psychology — Wellesley College, 1976

2. ADVISORY ACTIVITIES
MacArthur Foundation, Consultant Writer to Mental Health Services & Public Policy Network, 2003-2008
AAAS Science Journalism Awards, Screening Committee Member, 2001 & 1999
Journal of Women’s Health Research and Gender-Based Medicine. Peer-reviewer, 1999-2000.
American Brain Tumor Association, Special Advisor, 1985--present;
AAAS Congressional Science Fellowship, Selection Committee Member, 1993--1994;
Science Panel of the Agent Orange Task Force, White House Domestic Policy Council Working Group, Member,
1990--1992;
National Cancer Advisory Board, Liaison Member, 1990--1992;
Parkinson's Disease Epidemiology Research Advisory Committee, Liaison Member, 1988--89;
US Health and Human Services Secretary's Task Force on Alzheimer's Disease, 1984.
APPOINTMENTS AND AWARDS
Co-authored Article in the American Journal of Psychiatry selected as one of top 6 publications of 2009.
Consultant (Medicine Service), Laboratory of Immunobiology, Massachusetts General Hospital. The laboratory
is associated with Harvard Medical School. 2007-present;
Adjunct Assistant Professor, Department of Epidemiology and Biostatistics, School of Public Health and Health
Services, George Washington University, 1995--2006;
Surgeon General’s Exemplary Service Award, 2001 & 1999 for contributions to Surgeon General’s Reports on
mental health.
Co-authored "Report on the Benefits and Risks of Fluoride," winner of the Office of the Assistant Secretary for
Health Special Recognition Award, 1992;
Co-authored "Report on the Financing of Long-Term Care," winner of the Secretary of the Department of Health
and Human Services' Commendation Award, 1987;
Office of the Assistant Secretary for Health Special Recognition Awards, in 1987 and 1985, for contributions to
national health policy;
Fellowships: Congressional Science Fellow, 1982--83 (Served at the Congressional Research Service with a
special assignment at the Office of Technology Assessment); National Institutes of Health Trainee, 1980--82;
National Science Foundation Graduate Fellowship, 1977--80; Public Health Service Award, 1979

3. SELECTED PUBLICATIONS — Grouped by Areas of Expertise
1) Neuroscience and Mental Health
2) Oncology
3) Stem Cell Biology, Juvenile Diabetes, and Immunology
4) Veteran and Military Medicine
5) Public Health & Other health-related topics
Neuroscience and Mental Health.
Davis M. Marijuana Use, Disorders Double in US Adults. Medscape Medical News, October 23, 2015.
http://www.medscape.com/viewarticle/853145
Davis M. Dietary Supplement May Help Treat Cocaine Dependence. Medscape Medical News, June 16, 2015.
http://www.medscape.com/viewarticle/846533
Davis, M. CBT Equal to Light Therapy for SAD. Medscape Medical News, May 11, 2015
http://www.medscape.com/viewarticle/844473
Davis, M. Experimental Drug Safe, Effective in Schizophrenia. Medscape Medical News, April 27 2015.
http://www.medscape.com/viewarticle/843777
Davis M. Mindfulness Therapy May offer Alternative to Antidepressants. Medscape Medical News, May 1,
2015. http://www.medscape.com/viewarticle/844073
Davis, M. Introduction to the Affordable Care Act and Mental Health Services. Chapter written for the IOM
Committee on Psychosocial Standards, June, 2014.
Davis M. Behavioral health sector serving disaster medicine. Chapter written for the IOM Committee on Post-
Disaster Recovery, July, 2014.
Davis M. Suicide prevention and PTSD prevention in the military. Chapter written as a consultant to the Institute
of Medicine Committee on the Readjustment Needs of Veterans, Service Members, and their Families, 2013
Posey Norris, S, Pankevich D, Davis M., Altevogt B. Improving and accelerating therapeutic development for
nervous system disorders: a workshop summary. Washington, DC: National Academies Press, 2014.
Davis M, Stroud C. Neurodegeneration: Exploring Commonalities across Diseases. Washington, DC: National
Academies Press, 2014.
Davis M. Family Violence. Chapter written as a consultant to the Institute of Medicine Committee on the
Readjustment Needs of Veterans, Service Members, and their Families, 2012.
Davis M. Bereavement and Family Programs. Chapter written as a consultant to the Institute of Medicine
Committee on the Readjustment Needs of Veterans, Service Members, and their Families, 2012.
Pankovich D, Davis M, Altevogt B. Glutamate-Related Biomarkers in Drug Development for Disorders of the
Nervous System. Washington, DC: National Academies Press, 2011.

4. North CS, Suris AM, Davis M, Smith RP. Toward Validation of the Diagnosis of Posttraumatic Stress Disorder.
American Journal of Psychiatry. 2009 (Award-winning article selected by the Journal’s Editors as one of the top 6
articles of the year. The journal is on par with the New England Journal of Medicine.)
Hanson S, Davis M, Altevogt. CNS Clinical Trials: Suicidality and Data Collection. Washington, DC: National
Academies Press, 2009.
Davis, M, Hanson, S, and Altevogt, B. Neuroscience Biomarkers and Biosignatures: Converging Technologies,
Emerging Partnerships. Washington, DC: National Academies Press, 2008.
Davis, M. Chapter on Epidemiology in Technical Series Report on Suicide Prevention for Individuals with
Serious Mentally Illness. NASHHPD, 2008
Collaborator, Goodwin & Jamison Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd
Edition, Oxford University Press, 2007. Author/Editor of three chapters.
Better But Not Well: Mental Health Policy in the United States Since 1950. R. Frank, S. Glied, with Davis,
Goldman and the Network. Baltimore: Johns Hopkins University Press, 2006.
Buchanan R, Davis M, Goff D et al, A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial
Design for Neurocognitive Drugs for Schizophrenia. Schizophr Bull. 2005 Jan;31(1):5-19.
Childhood Depression and Suicide: Impact of SSRIs. Consultant and writer, the Task Force on Childhood
Depression and Suicide of the ACNP (American College of Neuropsychopharmacology), 2004. (Served as
medical writer)
Davis, M. 2004. Biology of Spinal Cord Injury. Chapter Written as Consultant to the Institute of Medicine
Committee on Spinal Cord Injury.
Davis, M. 2004. Therapeutic Targets for Treating Spinal Cord Injury. Chapter written as Consultant to the
Institute of Medicine Committee on Spinal Cord Injury.
Davis, M. 2004. State Programs in Spinal Cord Injury. Chapter written as Consultant to the Institute of Medicine
Committee on Spinal Cord Injury.
Center C, Davis M, Detre T et al, 2003. Confronting depression and suicide in physicians. A Consensus
Statement Journal of the American Medical Association (JAMA), 289 (23):3161-3166.
Interim Report to the President by the New Freedom Commission on Mental Health, 2002. (Served as senior
medical writer)
Davis, M. Mental illness and HIV comorbidity. Chapter written as Consultant to the IOM Committee on Public
Financing and Delivery of HIV Care. November, 2002.
Davis M. Learning from a troubled genius. Washington Post, health section front page, F1, December 18, 2001.
Mental Health: A Report of the Surgeon General. Rockville, Maryland: U.S. Department of Health and Human
Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services,
National Institutes of Health, National Institute of Mental Health, 1999 (500 pages). (Served as senior medical
writer and editor.)
M. Davis. Development of cannabinoid drugs. Chapter in the IOM report, Marijuana and Medicine: Assessing

5. the Science Base, National Academy Press, Washington, DC, 1999.
Jacobs MJ, Fischback GD, Davis, M et al. Future directions for epilepsy research. Neurology 2001 57: 1536-
1542
Mental Health of Racial and Ethnic Minorities: A Report of the Surgeon General. Rockville, Maryland: U.S.
Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center
for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 2001 (200 pages).
(Served as senior medical writer)
Davis M. Childhood Trauma and Suicide. Chapter written as Consultant to the IOM Committee on the
Pathophysiology of Adolescent and Adult Suicide. November, 2001.
Davis M. Barriers to Health Services and Treatment. Chapter written as Consultant to the IOM Committee on the
Pathophysiology of Adolescent and Adult Suicide. November, 2001.
Davis, M. The integration of mental health services into primary health care. Report of a Surgeon General
conference, 2001. http://www.surgeongeneral.gov/library/mentalhealthservices/mentalhealthservices.html
Kitt, C, Gruber, K, Davis, M, Levine, J and Woolf, C. 2000. Trigeminal neuralgia: opportunities for research and
treatment. Pain 85 (1-2):3-7.
National Institute of Mental Health, Finding the Balance: Report of the National Institute of Mental Health
Intramural Research Planning Committee. 1997. (Served as science writer)
Davis, M. Methadone treatment. Chapter in IOM Report, Federal Regulation of Methadone Treatment, National
Academy Press, Washington, DC, 1995.
Davis, M. 1995. Background planning report for an evaluation of the NIDR Centers Program. Prepared for the
National Institute of Dental Research, Office of the Director.
Davis, M. Women's Health and Davis, M. Introduction to Neuroscience and Drug Abuse. Chapter prepared for
the Institute of Medicine, 1996. Chapter appeared in Pathways of Addiction: Opportunities in Drug Abuse
Research. Washington D.C.: National Academy Press.
Davis, M. Managed Care and Substance Abuse Treatment. Chapter prepared for the Institute of Medicine, 1996.
Chapter appeared in Pathways of Addiction: Opportunities in Drug Abuse Research. Washington D.C.: National
Academy Press.
Davis, M. The Impact of Financing and Health Care Reform on Pharmaceutical Investment in Anti-Addiction
Medications. Chapter in the Institute of Medicine report, The Development Of Medications For The Treatment Of
Opiate And Cocaine Addiction: Issues For The Government And The Private Sector. 1994.
Davis, M. The Current Market for Anti-Addiction Medications. Chapter in the Institute of Medicine report, The
Development Of Medications For The Treatment Of Opiate And Cocaine Addiction: Issues For The Government
And The Private Sector. 1994.
Davis, M. Model Federal Programs in Pharmaceutical R&D. Chapter in the Institute of Medicine report, The
Development Of Medications For The Treatment Of Opiate And Cocaine Addiction: Issues For The Government
And The Private Sector. 1994.
H. Goldman, G. Cohen and M. Davis. Expanded Medicare Outpatient Coverage for Alzheimer's Disease and
Related Disorders. Hospital and Community Psychiatry, 36: 939-942. 1985.

6. M. Davis. Federal Role in Neuroscience Research and Regulation. Congressional Research Service, 1983.
(Incorporated in Office of Technology Assessment Report on "The Impacts of Neuroscience Research," 1984.)
M. Davis, M. Constantine-Paton and D. Schoor. Dorsal Root Ganglion Removal Produces Fewer Motoneurons.
Brain Research, 265: 283-288, 1983.
M. Davis and M. Constantine-Paton. Hyperplasia in the Spinal Sensory System of the Frog. I. Plasticity in the
Most Caudal Dorsal Root Ganglion. Journal of Comparative Neurology, 221: 444-452, 1983.
M. Davis and M. Constantine-Paton. Hyperplasia in the Spinal Sensory System of the Frog. II. Central and
Peripheral Connectivity Patterns. Journal of Comparative Neurology, 221: 453-465, 1983.
2. Oncology
Davis M. Advanced breast cancer: adding palbociclib to letrozole boosts PFS. Univadis Medical News, Nov. 16,
2016.
Davis M. Lovastatin lowers breast cancer risk by 40%. Nov. 18, 2016.
Davis M. Nurses' Health Study: higher protein intake reduces breast cancer recurrence. Nov. 17, 2016.
Davis M. Advanced breast cancer: adding palbociclib to first-line letrozole improves PFS. Nov. 14, 2016.
Davis M. Breast cancer: women with history of depression less likely to receive optimal care. Nov. 16, 2016
Davis M. Postmenopausal breast cancer: 30% of cases are avoidable. Nov. 16, 2016
Davis M. MTHFR polymorphism raises breast cancer risk. Nov. 10, 2016
Davis M. High-risk early breast cancer: no survival benefit for dose-dense chemotherapy. Nov. 9, 2016
Davis M. Breast cancer: capecitabine, doxorubicin + docetaxel found most toxic. Nov. 9, 2016
Davis M. Breast cancer: delaying surgery >21 d undercuts NACT benefit. Nov. 4, 2016
Davis M. HER2-positive breast cancer: how effective is dual block with lapatinib and trastuzumab versus
trastuzumab alone combined with chemotherapy? A meta-analysis. Univadis Medical News, May 6, 2016.
http://www.univadis.com/viewarticle/her2-positive-breast-cancer-how-effective-is-dual-block-with-lapatinib-and-
trastuzumab-versus-trastuzumab-alone-combined-with-chemotherapy-a-meta-analysis-401998?s1=news
Davis M. Metastatic breast cancer: is bevacizumab safe and effective when added to letrozole for hormone
receptor-positive cancer? A phase 3 trial. Univadis Medical News, May 6, 2016.
http://www.univadis.com/viewarticle/metastatic-breast-cancer-is-bevacizumab-safe-and-effective-when-added-to-
letrozole-for-hormone-receptor-positive-cancer-a-phase-3-trial-402047?s1=news
400 other breast cancer articles for Univadis Medical News can be found by searching “breast cancer” at
http://www.univadis.com/
Davis, M. The Human Genome Atlas. “Story of Discovery” written for the National Cancer Institute.

7. 3.Stem Cell Biology, Juvenile Diabetes, and Immunology
Faustman DL and Davis M. Early- vs Late-Onset Type 1 Diabetes: Two Different Pathophysiological Subtypes
with Implications for Therapy. Invited chapter in book, Autoimmunity, by InTech Press, scheduled for publication
in 2016 or 2017.
Faustman DL and Davis M. Historic and emerging applications of BCG in prevention and treatment of disease.
Medical Research Archives 2015, Vol 2, Number 8.
Faustman DL and Davis M. The Pancreas Secretes Insulin for Decades after Onset of Type I Diabetes:
Implications for Care and Management. Major Topics in Type 1 Diabetes, Nunes KP (editor),2015.
Faustman DL, Davis M. Disposable No Longer: The Spleen Holds a Reservoir of Stem Cells. Journal of Stem
Cell Research and Therapy 2014; 4:7.
Faustman DL and Davis M. TNF receptor 2 and disease: autoimmunity and regenerative medicine. Frontiers in
Immunology, December 2013, 4:478.
Faustman DL, Davis M. Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I
diabetes, and other disorders. Int J Biochem Cell Biol. 2010 Oct;42(10):1576-9.
Okubo Y1
, Mera T, Wang L, Faustman DL. Homogeneous expansion of human T-regulatory cells via tumor
necrosis factor receptor 2. Nature Sci Rep. 2013 Nov 6;3:3153 (served as Editor)
Limei Wang, Nicholas Lovejoy, Denise L. Faustman. Persistence of Prolonged C-peptide Production in Type
I Diabetes with an Ultrasensitive C-peptide Assay. Diabetes Care, 2012 Mar;35(3):465-70 (served as Editor)
Faustman D and Davis M. Tumor Necrosis Factor Receptor 2 pathway: Drug target for autoimmune diseases
Nature Drug Discov. 2010 Jun;9(6):482-93.
Faustman D and Davis M. Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes,
and other disorders. Int J Biochem Cell Biol. 2010 Oct;42(10):1576-9.
Faustman, DL & Davis, M. The Primacy of CD8 T-lymphocytes in Type 1 Diabetes and implications for
therapies. Journal of Molecular Medicine, Volume 87, Issue 12 (2009), Page 1173.
Faustman D and Davis M. Immunotherapy for type I diabetes takes aim at autoreactive T cells. Reviews of
Endocrinology, January 2009.
Lonyai A, Kodama S, Burger D, Davis M, Faustman DL.The promise of Hox11+ stem cells of the spleen for
treating autoimmune diseases. Horm Metab Res. 2008 Feb;40(2):137-46.
F J Dieguez-Acuna, S P Gygi, M Davis and D L Faustman. Splenectomy: a new treatment option for ALL tumors
expressing Hox-11 and a means to test the stem cell hypothesis of cancer in humans. Nature Leukemia. E-
publication August 16, 2007
Dale, E, Davis M, Faustman DF. A role for transcription factor NF-kappaB in autoimmunity: possible interactions
of genes, sex, and the immune response. Adv Physiol Educ. 2006 Dec;30(4):152-8.
Faustman DL, Davis, M, Kodama S. Stem cell research turns to the lowly spleen. Science Magazine, Online
journal SAGE KE, January 19, 2005 (3):pe2.

8. Kodama S, Davis, M, Faustman D. The therapeutic potential of tumor necrosis factor for autoimmune disease: a
mechanistically-based hypothesis. Cellular and Molecular Life Sciences June, 2005 62(16):1850-62.
Kodama S, Davis, M, Faustman D. Regenerative Medicine: A Radical Reappraisal of the Spleen. Trends in
Molecular Medicine 2005 Jun;11(6):271-6.
Davis, M. Xenografts: Immunology, Molecular Biology, and Public Policy. Report prepared for the Institute of
Medicine, Committee on Xenotransplantation, 1995.
4.Veteran and Military Medicine
Davis M. Chronic Multisymptom Illness in Gulf War Veterans, 2014 . Chapter written for IOM Committee on
the Development of a Consensus Case Definition for Chronic Multisymptom Illness in 1990-1991.
Davis M. Suicide prevention in the US military. Chapter Written for the IOM Committee on the Assessment of
Readjustment Needs of Military Personnel, Veterans, and their Families, 2013.
Davis M. Prevention programs for mental disorders. Written for the IOM Committee on the Assessment of
Readjustment Needs of Military Personnel, Veterans, and their Families, 2013.
Davis M. Historical perspective on the health effects of blast exposure. Written for the IOM Committee on the
Long-term Effects of Blast Exposure, 2012.
Davis, M. Community effects of Deployment to Iraq or Afghanistan. Edited chapter for the IOM Committee on
the Readjustment Needs of OIF/OEF veterans, 2012
North CS, Suris AM, Davis M, Smith RP. Toward Validation of the Diagnosis of Posttraumatic Stress Disorder.
American Journal of Psychiatry. 2009 (Award-winning article selected by the Journal’s Editors as one of top 6
articles of the year. The journal is to the mental health field the equivalent of the New England Journal of
Medicine to medicine as a whole.)
Davis, M. Consultant/Writer for IOM Committee on Health Effects of Stress in War, 2006-2008.
Davis, M. Chapter on Epidemiology, Diagnosis & Assessment of Post Traumatic Stress Disorder. Consultant to
IOM Committee on Gulf War and Health: Physiologic, Psychologic, and Psychosocial Effects of War-Related
Stress. Board on Population Health and Public Health Practice, 2006.
The Impact of Terrorism on Brain And Behavior: What We Know And What We Need To Know.
Interdisciplinary Task Force on Terrorism of the ACNP (American College of Neuropsychopharmacology) 2004.
(Served as medical writer)
Davis, M. Neurological effects of fuels and oil well fires in the Gulf War. Chapter Written as Consultant to the
IOM Committee on the Health Effects of the Gulf War, 2004.
Davis, M. Neurological effects of pesticides and solvents. Chapter written as Consultant to the IOM Committee
on the Health Effects of the Gulf War, 2003.
Davis, M. Sarin toxicology and epidemiology. Chapter written as Consultant to the Institute of Medicine report,
Gulf War and Health, 2000.
Davis, M. Illnesses in Gulf War veterans. Chapter written as Consultant to Institute of Medicine, Gulf War and
Health, 2000.

9. Davis, M. Exposure assessment. Chapter prepared for the Institute of Medicine report, Gulf War and Health,
2000.
Davis, M. Clinical Technology Sharing Issues in Coordinating Federal Health Care Resources. Prepared under
contract to Birch and Davis, Associates, Inc. for a 1993 Conference jointly sponsored by the Department of
Veterans Affairs, the Department of Defense, and the Indian Health Service, "Coordinating Federal Health Care:
Progress and Promise." 1993.
M. Davis. Agent Orange: Veterans' Complaints and Studies of Health Effects. Congressional Research Service,
1983.
5. Other Health-Related Topics
Davis, M. Regional disaster response coordination to support health outcomes: A workshop series. Institute of
Medicine, Forum on Medical and Public Health Preparedness for Catastrophic Events. Washington, DC:
National Academies Press, in press.
Davis, M, Reeve M, Altevogt B. Nationwide response issues after an Improvised Nuclear Device Attack:
Medical and public health considerations for Neighboring Jurisdictions. National Academies Press, Washington,
DC: 2014.
Davis, M and Altevogt, B. Medical Countermeasures Dispensing during Public Health Emergencies. National
Academies Press, Washington, DC: 2008.
Davis, M. The Public Health Consequences of Sleep Disorders. Chapter written as Consultant to the Institute of
Medicine (IOM) Committee on Sleep Research, 2006.
Davis, M. Introduction to Sleep Disorders. Chapter written as Consultant to IOM Committee on Sleep Research,
2006.
Davis, M. Estimating the contributions of lifestyle-related factors to preventable death. Report Written as
Consultant to Institute of Medicine, 2005.
Davis, M. The Medicolegal Death Investigation System. Chapter written as Consultant to the Institute of
Medicine, Committee for the Workshop on the Death Investigation System, 2003.
Rausch D and Davis M. HIV in the CNS: Pathogenic relationships to systemic disease and other CNS diseases.
Journal of NeuroVirology 2001 Apr;7(2):85-96.
Davis, M. The magnitude of youth violence. Chapter in Surgeon General report on Youth Violence, 2001.
Davis, M. The developmental characteristics of youth violence. Chapter in Surgeon General Report on Youth
Violence, 2001.
Davis, M. How a new disease comes to be identified and labeled in medicine. Appendix in Institute of Medicine
report, Gulf War and Health, 2000. Resubmitted for publication in the Annals of Internal Medicine.
Davis, M. Public health and managed care. Report of an American Public Health Association Conference,
December, 2000.
Davis, M. The SIV Model of HIV-associated dementia. Prepared for the National Institute of Mental Health,

10. 2000. Manuscript posted on the NeuroAIDS website, a peer-reviewed forum of Science Magazine.
Davis, M. HIV and the Nervous System: A Symposium. Prepared for the National Institute of Mental Health,
2000.
Davis, M. Methods of epidemiology. Chapter in Institute of Medicine report, Gulf War and Health, 2000.
Women’s health and the Environment. Report prepared for the Society for the Advancement of Women's Health
Research, 1995. Chapters include: Drug Abuse, Estrogens and the Environment, Prescription Drugs, Smoking,
and Electromagnetic Fields.
Davis, M. Federal Programs in injury prevention and control. Chapter in IOM report, Reducing the Burden of
Injury, National Academy Press, Washington, DC, 1999.
Davis, M. Trauma systems: Acute care through rehabilitation. Chapter in IOM report, Reducing the Burden of
Injury, National Academy Press, Washington, DC, 1999.
National Cancer Institute, Progress Review Group Report on Prostate Cancer, 1998. (was co-medical writer.)
Davis, M. Prevention of perinatal transmission of HIV. Reports of workshops and site visits for the Institute of
Medicine, 1998.
Strategic Plan of the National Institute of Dental Research, NIH. 1997. (Served as science writer.)
Davis, M. Summaries of Award-Winning PHS evaluation studies. Published in: Performance Improvement-
Evaluation Activities of the PHS, USDHHS. 1996, 1995.
Davis, M. Profiles of student projects in molecular biology research supported by the Howard Hughes Medical
Institute (HHMI). Prepared for HHMI, 1997,1996, 1995.
Davis, M. Profiles of science education courses in molecular biology supported by the Howard Hughes Medical
Institute (HHMI). Prepared for HHMI, 1997,1996, 1995.
Davis, M. Risks to Children in Schools: Lead and Electromagnetic Fields. Chapter appeared in report by the
U.S. Congressional Office of Technology Assessment, 1994.
Davis, M. Meeting to Review Data Collection and Analysis by the Office of Applied Studies. Report prepared
for the Substance Abuse and Mental Health Services Administration, 1994.
Davis, M. Assessment of the Medications Development Division of the National Institute on Drug Abuse.
Report prepared for the Institute of Medicine, 1993. Report appeared as chapter in an Institute of Medicine
Report, Development of Anti-Addiction Medications: Issues for the Government and Private Sector.
Davis, M. Health Risk Assessment Research at the Department of Energy and Issues and Options for Risk
Assessment Research Policy. Prepared for the U.S. Office of Technology Assessment. 1992.
Public Health Service, Report on the Benefits and Risks of Fluoride. Committee to Coordinate Environmental
Health and Related Programs, Ad Hoc Working Group on Fluoride, 1991. (Co-author with members of the
Working Group. Wrote Executive Summary, Preface, Abstract, Introduction and Recommendations.)
M. Davis. Report on the Regulation of Steroids, Growth Hormone and Butyl Nitrite. Prepared for the Interagency
Committee on Drug Control, 1988.

11. Department of Health and Human Services, Report on the Financing of Long-Term Care, 1987. (Co-author)
M. Davis. Premenstrual Syndrome. In: The Final Report of the U.S. Public Health Service Task Force on
Women's Health Issues, 1984.